Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of thymomas.

Cameron D Wright1

  • 1Division of Thoracic Surgery, Massachusetts General Hospital, Harvard Medical School, Blake 1570, Boston, MA 02114, USA. wright.cameron@mgh.harvard.edu

Critical Reviews in Oncology/Hematology
|June 16, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The implementation of an electronic symptom management system to monitor postoperative pain in thoracic surgery patients: A multicenter evaluation.

JTCVS open·2025
Same author

Continuing Certification for Diplomates of the American Board of Thoracic Surgery.

The Journal of thoracic and cardiovascular surgery·2025
Same author

Supporting Professionalism: Introduction of 360 Degree Review to the Credentialing Process by the American Board of Thoracic Surgery.

The Annals of thoracic surgery·2025
Same author

Supporting Professionalism: Introduction of 360 Degree Review to the Credentialing Process by the American Board of Thoracic Surgery.

The Journal of thoracic and cardiovascular surgery·2025
Same author

Carinal Resections-Not for the Faint of Heart.

The Annals of thoracic surgery·2024
Same author

Does Surgical Removal of the Thymus Have Deleterious Consequences?

Neurology·2024
Same journal

Opportunities and Challenges of Dihydrodiol dehydrogenase Expression in Hepatocellular carcinoma.

Critical reviews in oncology/hematology·2026
Same journal

Ferroptosis in Glioblastoma: Molecular Determinants, Immune Crosstalk, and Therapeutic Opportunities.

Critical reviews in oncology/hematology·2026
Same journal

Beyond Oncogenesis: The emerging role of EZH2 in Tumor Microenvironment.

Critical reviews in oncology/hematology·2026
Same journal

Cross-Scale Bioanalytical Integration for Decoding Tumour Regulatory Plasticity in Oncology.

Critical reviews in oncology/hematology·2026
Same journal

Organoids in Biliary Tract Cancers: Advances in Modeling Strategies and Translational Applications.

Critical reviews in oncology/hematology·2026
Same journal

Corrigendum to "Management of atypical cartilaginous tumors (ACT): An Italian Sarcoma Group (ISG) consensus document" [Crit. Rev. Oncol. Hematol. 223 (2026) 105358].

Critical reviews in oncology/hematology·2026
See all related articles

Thymoma, a rare cancer, is often slow-growing but can invade locally. Surgical treatment offers high cure rates for early stages, while multimodal therapy benefits advanced cases.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Neoplastic Diseases

Background:

  • Thymoma is a rare tumor of the thymus gland.
  • It typically exhibits indolent growth but can invade locally or metastasize.
  • A significant association exists with paraneoplastic syndromes, most notably myasthenia gravis.

Purpose of the Study:

  • To review the management and prognostic factors of thymoma.
  • To highlight the role of surgery and multimodality therapy in thymoma treatment.

Main Methods:

  • Review of literature on thymoma diagnosis, treatment, and prognosis.
  • Analysis of prognostic indicators including Masaoka stage, WHO histology, resection status, and tumor size.

Main Results:

Related Experiment Videos

  • Surgery is the standard for early-stage thymoma, yielding high cure rates.
  • Masaoka stage, WHO histology, complete resection, and size are key prognostic factors.
  • Multimodality therapy improves outcomes for locally advanced, unresectable thymomas.

Conclusions:

  • Complete surgical resection is crucial for early-stage thymoma.
  • Adjuvant therapies like chemotherapy and radiation are effective for advanced or unresectable thymoma.
  • Prognosis is influenced by staging, histology, and treatment completeness.